Banuelos, C.A.; Ito, Y.; Obst, J.K.; Mawji, N.R.; Wang, J.; Hirayama, Y.; Leung, J.K.; Tam, T.; Tien, A.H.; Andersen, R.J.;
et al. Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants. Cancers 2020, 12, 1991.
https://doi.org/10.3390/cancers12071991
AMA Style
Banuelos CA, Ito Y, Obst JK, Mawji NR, Wang J, Hirayama Y, Leung JK, Tam T, Tien AH, Andersen RJ,
et al. Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants. Cancers. 2020; 12(7):1991.
https://doi.org/10.3390/cancers12071991
Chicago/Turabian Style
Banuelos, Carmen A., Yusuke Ito, Jon K. Obst, Nasrin R. Mawji, Jun Wang, Yukiyoshi Hirayama, Jacky K. Leung, Teresa Tam, Amy H. Tien, Raymond J. Andersen,
and et al. 2020. "Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants" Cancers 12, no. 7: 1991.
https://doi.org/10.3390/cancers12071991
APA Style
Banuelos, C. A., Ito, Y., Obst, J. K., Mawji, N. R., Wang, J., Hirayama, Y., Leung, J. K., Tam, T., Tien, A. H., Andersen, R. J., & Sadar, M. D.
(2020). Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants. Cancers, 12(7), 1991.
https://doi.org/10.3390/cancers12071991